Pfizer estimates US$15 billion in 2021 sales for Covid-19 vaccine

SALES of the Covid-19 vaccine developed by Pfizer and BioNTech could reach up to US$15 billion (RM60.7 billion) this year and go higher if Pfizer signs additional supply contracts, Pfizer said today.

The projections came as Pfizer projected full-year 2021 sales of between US$59.4 billion and US$61.4 billion, meaning that about one-fourth of estimated total sales will come from the Covid-19 vaccine.